Skip to main content
Top
Published in: Journal of Neurology 2/2017

01-02-2017 | Original Communication

Comparison of cerebrospinal fluid profiles in Alzheimer’s disease with multiple cerebral microbleeds and cerebral amyloid angiopathy-related inflammation

Authors: Akio Kimura, Masao Takemura, Kuniaki Saito, Nobuaki Yoshikura, Yuichi Hayashi, Naoko Harada, Hiroshi Nishida, Hideto Nakajima, Takashi Inuzuka

Published in: Journal of Neurology | Issue 2/2017

Login to get access

Abstract

Brain magnetic resonance imaging (MRI) of patients with Alzheimer’s disease (AD) sometimes reveals multiple cerebral microbleeds (CMBs) and confluent white matter hyperintensities (WMHs) similar to those observed in cerebral amyloid angiopathy-related inflammation (CAA-I). To determine whether there might be common pathophysiological mechanisms underlying the MRI findings of multiple CMBs and confluent WMHs, we investigated the cerebrospinal fluid (CSF) profiles of 38 AD, five amnestic mild cognitive impairment (MCI), and six CAA-I patients. The AD and MCI patients were divided into groups of patients with (n = 10) or without (n = 33) multiple CMBs (n ≥ 2) on T2*-gradient echo sequences of brain MRI. We compared the CSF profiles of AD and MCI patients with or without multiple CMBs, and CAA-I patients. The brain MRIs of the patients with multiple CMBs revealed severe degrees of WMHs compared with the patients without multiple CMBs. The levels of CSF anti-amyloid β autoantibody and interleukin 8, and CSF/serum albumin ratios and immunoglobulin G indexes, were significantly higher in CAA-I patients than the other groups. However, there were no significant differences in the CSF profiles of patients with or without multiple CMBs. Our study provides evidence for different pathophysiological mechanisms underlying these differential MRI findings in AD and CAA-I.
Literature
1.
go back to reference Vinters HV, Gilbert JJ (1983) Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke 14:924–928CrossRefPubMed Vinters HV, Gilbert JJ (1983) Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke 14:924–928CrossRefPubMed
2.
go back to reference Jellinger KA (2002) Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm (Vienna) 109:813–836CrossRef Jellinger KA (2002) Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm (Vienna) 109:813–836CrossRef
3.
go back to reference Ellis RJ, Olichney JM, Thal LJ et al (1996) Cerebral amyloid angiopathy in the brains of patients with Alzheimer’s disease: the CERAD experience, Part XV. Neurology 46:1592–1596CrossRefPubMed Ellis RJ, Olichney JM, Thal LJ et al (1996) Cerebral amyloid angiopathy in the brains of patients with Alzheimer’s disease: the CERAD experience, Part XV. Neurology 46:1592–1596CrossRefPubMed
4.
go back to reference Eng JA, Frosch MP, Choi K et al (2004) Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol 55:250–256CrossRefPubMed Eng JA, Frosch MP, Choi K et al (2004) Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol 55:250–256CrossRefPubMed
5.
go back to reference Oh U, Gupta R, Krakauer JW et al (2004) Reversible leukoencephalopathy associated with cerebral amyloid angiopathy. Neurology 62:494–497CrossRefPubMed Oh U, Gupta R, Krakauer JW et al (2004) Reversible leukoencephalopathy associated with cerebral amyloid angiopathy. Neurology 62:494–497CrossRefPubMed
6.
go back to reference Scolding NJ, Joseph F, Kirby PA et al (2005) Abeta-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain 128:500–515CrossRefPubMed Scolding NJ, Joseph F, Kirby PA et al (2005) Abeta-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain 128:500–515CrossRefPubMed
7.
go back to reference Salvarani C, Hunder GG, Morris JM et al (2013) Aβ-related angiitis comparison with CAA without inflammation and primary CNS vasculitis. Neurology 81:1596–1603CrossRefPubMedPubMedCentral Salvarani C, Hunder GG, Morris JM et al (2013) Aβ-related angiitis comparison with CAA without inflammation and primary CNS vasculitis. Neurology 81:1596–1603CrossRefPubMedPubMedCentral
8.
go back to reference DiFrancesco JC, Brioschi M, Brighina L et al (2011) Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report. Neurology 76:842–844CrossRefPubMed DiFrancesco JC, Brioschi M, Brighina L et al (2011) Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report. Neurology 76:842–844CrossRefPubMed
9.
go back to reference Chung KK, Anderson NE, Hutchinson D et al (2011) Cerebral amyloid angiopathy related inflammation: three case reports and a review. J Neurol Neurosurg Psychiatry 82:20–26CrossRefPubMed Chung KK, Anderson NE, Hutchinson D et al (2011) Cerebral amyloid angiopathy related inflammation: three case reports and a review. J Neurol Neurosurg Psychiatry 82:20–26CrossRefPubMed
10.
go back to reference McKhann G, Drachman D, Folstein M et al (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34:939–944CrossRefPubMed McKhann G, Drachman D, Folstein M et al (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34:939–944CrossRefPubMed
12.
go back to reference Galimberti D, Schoonenboom N, Scheltens P et al (2006) Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease. Arch Neurol 63:538–543CrossRefPubMed Galimberti D, Schoonenboom N, Scheltens P et al (2006) Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease. Arch Neurol 63:538–543CrossRefPubMed
13.
go back to reference Fazekas F, Chawluk JB, Alavi A et al (1987) MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. Am J Roentgenol 149:351–356CrossRef Fazekas F, Chawluk JB, Alavi A et al (1987) MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. Am J Roentgenol 149:351–356CrossRef
14.
go back to reference Schmidt R, Fazekas F, Kapeller P et al (1999) MRI white matter hyperintensities: 3-year follow-up of the Austrian Stroke Prevention Study. Neurology 53:132–139CrossRefPubMed Schmidt R, Fazekas F, Kapeller P et al (1999) MRI white matter hyperintensities: 3-year follow-up of the Austrian Stroke Prevention Study. Neurology 53:132–139CrossRefPubMed
15.
go back to reference Kundsen K, Rosand J, Karluk D et al (2001) Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology 56:537–539CrossRef Kundsen K, Rosand J, Karluk D et al (2001) Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology 56:537–539CrossRef
16.
go back to reference Melzer N, Harder A, Gross CC et al (2012) CD4(+) T cells predominate in cerebrospinal fluid and leptomeningeal and parenchymal infiltrates in cerebral amyloid β-related angiitis. Arch Neurol 69:773–777CrossRefPubMed Melzer N, Harder A, Gross CC et al (2012) CD4(+) T cells predominate in cerebrospinal fluid and leptomeningeal and parenchymal infiltrates in cerebral amyloid β-related angiitis. Arch Neurol 69:773–777CrossRefPubMed
17.
go back to reference Charidimou A, Gang Q, Werring DJ (2012) Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. J Neurol Neurosurg Psychiatry 83:124–137CrossRefPubMed Charidimou A, Gang Q, Werring DJ (2012) Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. J Neurol Neurosurg Psychiatry 83:124–137CrossRefPubMed
18.
go back to reference Kinnecom C, Lev MH, Wendell L et al (2007) Course of cerebral amyloid angiopathy-related inflammation. Neurology 68:1411–1416CrossRefPubMed Kinnecom C, Lev MH, Wendell L et al (2007) Course of cerebral amyloid angiopathy-related inflammation. Neurology 68:1411–1416CrossRefPubMed
19.
go back to reference Piazza F, Greenberg SM, Savoiardo M et al (2013) Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies. Ann Neurol 73:449–458CrossRefPubMed Piazza F, Greenberg SM, Savoiardo M et al (2013) Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies. Ann Neurol 73:449–458CrossRefPubMed
20.
go back to reference Ganrot K, Laurell CB (1974) Measurement of IgG and albumin content of cerebrospinal fluid, and its interpretation. Clin Chem 20:571–573PubMed Ganrot K, Laurell CB (1974) Measurement of IgG and albumin content of cerebrospinal fluid, and its interpretation. Clin Chem 20:571–573PubMed
21.
go back to reference Tibbling G, Link H, Ohman S (1977) Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest 37:385–390CrossRefPubMed Tibbling G, Link H, Ohman S (1977) Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest 37:385–390CrossRefPubMed
23.
go back to reference Pantoni L (2010) Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 9:689–701CrossRefPubMed Pantoni L (2010) Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 9:689–701CrossRefPubMed
24.
go back to reference Gouw AA, Seewann A, van der Flier WM et al (2010) Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry 82:126–135CrossRefPubMed Gouw AA, Seewann A, van der Flier WM et al (2010) Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry 82:126–135CrossRefPubMed
25.
go back to reference Kimberly WT, Gilson A, Rost NS et al (2009) Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy. Neurology 72:1230–1235CrossRefPubMedPubMedCentral Kimberly WT, Gilson A, Rost NS et al (2009) Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy. Neurology 72:1230–1235CrossRefPubMedPubMedCentral
26.
go back to reference Potter GM, Doubal FN, Jackson CA et al (2010) Counting cavitating lacunes underestimates the burden of lacunar infarction. Stroke 41:267–272CrossRefPubMed Potter GM, Doubal FN, Jackson CA et al (2010) Counting cavitating lacunes underestimates the burden of lacunar infarction. Stroke 41:267–272CrossRefPubMed
27.
go back to reference Gregoire SM, Charidimou A, Gadapa N et al (2011) Acute ischaemic brain lesions in intracerebral haemorrhage: multicentre cross-sectional magnetic resonance imaging study. Brain 134:2376–2386CrossRefPubMed Gregoire SM, Charidimou A, Gadapa N et al (2011) Acute ischaemic brain lesions in intracerebral haemorrhage: multicentre cross-sectional magnetic resonance imaging study. Brain 134:2376–2386CrossRefPubMed
28.
go back to reference Sperling RA, Jack CR Jr, Black SE (2011) Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer’s Association Research Roundtable Workgroup. Alzheimers Dement 7:367–385CrossRefPubMedPubMedCentral Sperling RA, Jack CR Jr, Black SE (2011) Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer’s Association Research Roundtable Workgroup. Alzheimers Dement 7:367–385CrossRefPubMedPubMedCentral
29.
go back to reference Sperling R, Salloway S, Brooks DJ (2012) Amyloid-related imaging abnormalities in patients with Alzheimer’s disease treated with bapineuzumab: a retrospective analysis. Lancet Neurol 11:241–249CrossRefPubMedPubMedCentral Sperling R, Salloway S, Brooks DJ (2012) Amyloid-related imaging abnormalities in patients with Alzheimer’s disease treated with bapineuzumab: a retrospective analysis. Lancet Neurol 11:241–249CrossRefPubMedPubMedCentral
30.
go back to reference Bach JP, Dodel R (2012) Naturally occurring autoantibodies against β-amyloid. Adv Exp Med Biol 750:91–99CrossRefPubMed Bach JP, Dodel R (2012) Naturally occurring autoantibodies against β-amyloid. Adv Exp Med Biol 750:91–99CrossRefPubMed
Metadata
Title
Comparison of cerebrospinal fluid profiles in Alzheimer’s disease with multiple cerebral microbleeds and cerebral amyloid angiopathy-related inflammation
Authors
Akio Kimura
Masao Takemura
Kuniaki Saito
Nobuaki Yoshikura
Yuichi Hayashi
Naoko Harada
Hiroshi Nishida
Hideto Nakajima
Takashi Inuzuka
Publication date
01-02-2017
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 2/2017
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-016-8362-2

Other articles of this Issue 2/2017

Journal of Neurology 2/2017 Go to the issue